Healthcare provider profile · identity verified

Thomas Jay Cox

Nurse Practitioner · TAYLORSVILLE, UT · NPI 1508511163

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	420	70
Gabapentin	Gabapentin	385	66
Furosemide	Furosemide	352	62
Trazodone Hcl	Trazodone Hcl	342	60
Lisinopril	Lisinopril	285	46
Levothyroxine Sodium	Levothyroxine Sodium	235	44
Amlodipine Besylate	Amlodipine Besylate	231	40
Eliquis	Apixaban	229	36
Omeprazole	Omeprazole	228	50
Oxycodone Hcl	Oxycodone Hcl	227	50
Potassium Chloride	Potassium Chloride	219	41
Metformin Hcl	Metformin Hcl	192	37
Escitalopram Oxalate	Escitalopram Oxalate	174	26
Losartan Potassium	Losartan Potassium	165	26
Buspirone Hcl	Buspirone Hcl	158	20
Duloxetine Hcl	Duloxetine Hcl	152	27
Aripiprazole	Aripiprazole	145	22
Pantoprazole Sodium	Pantoprazole Sodium	141	24
Tamsulosin Hcl	Tamsulosin Hcl	139	26
Metoprolol Succinate	Metoprolol Succinate	133	27
Quetiapine Fumarate	Quetiapine Fumarate	119	20
Sertraline Hcl	Sertraline Hcl	118	18
Spironolactone	Spironolactone	114	21
Metoprolol Tartrate	Metoprolol Tartrate	93	14
Oxybutynin Chloride	Oxybutynin Chloride	86	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	84	27
Levetiracetam	Levetiracetam	83	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	82	19
Lamotrigine	Lamotrigine	81	13
Carvedilol	Carvedilol	80	12
Fluoxetine Hcl	Fluoxetine Hcl	79	11
Famotidine	Famotidine	77	12
Mirtazapine	Mirtazapine	76	12
Donepezil Hcl	Donepezil Hcl	73	13
Pregabalin	Pregabalin	73	14
Tramadol Hcl	Tramadol Hcl	69	23
Alendronate Sodium	Alendronate Sodium	68	suppressed
Baclofen	Baclofen	67	13
Rosuvastatin Calcium	Rosuvastatin Calcium	66	11
Xarelto	Rivaroxaban	66	suppressed
Lorazepam	Lorazepam	65	19
Methocarbamol	Methocarbamol	64	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	63	suppressed
Clopidogrel	Clopidogrel Bisulfate	62	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	62	21
Ondansetron Odt	Ondansetron	61	35
Bupropion Xl	Bupropion Hcl	60	13
Torsemide	Torsemide	59	suppressed
Levofloxacin	Levofloxacin	58	29
Tizanidine Hcl	Tizanidine Hcl	58	13
Divalproex Sodium	Divalproex Sodium	57	13
Celecoxib	Celecoxib	53	14
Citalopram Hbr	Citalopram Hydrobromide	53	12
Methenamine Hippurate	Methenamine Hippurate	53	11
Simvastatin	Simvastatin	52	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	51	suppressed
Meloxicam	Meloxicam	50	12
Montelukast Sodium	Montelukast Sodium	46	11
Topiramate	Topiramate	46	suppressed
Cephalexin	Cephalexin	45	23
Propranolol Hcl	Propranolol Hcl	45	suppressed
Warfarin Sodium	Warfarin Sodium	45	suppressed
Nystatin	Nystatin	43	20
Glipizide Er	Glipizide	42	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	41	15
Divalproex Sodium Er	Divalproex Sodium	41	suppressed
Bupropion Hcl Sr	Bupropion Hcl	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	40	12
Risperidone	Risperidone	40	suppressed
Bumetanide	Bumetanide	38	suppressed
Metformin Hcl Er	Metformin Hcl	38	suppressed
Ondansetron Hcl	Ondansetron Hcl	38	suppressed
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Morphine Sulfate	Morphine Sulfate	37	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	11
Diclofenac Sodium	Diclofenac Sodium	32	13
Finasteride	Finasteride	32	suppressed
Memantine Hcl	Memantine Hcl	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	15
Fluconazole	Fluconazole	30	12
Myrbetriq	Mirabegron	30	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Clonazepam	Clonazepam	29	14
Easy Touch Pen Needle	Pen Needle, Diabetic	29	suppressed
Estradiol	Estradiol	29	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Jardiance	Empagliflozin	29	suppressed
Lidocaine	Lidocaine	29	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Midodrine Hcl	Midodrine Hcl	27	suppressed
Glimepiride	Glimepiride	26	suppressed
Haloperidol	Haloperidol	26	suppressed
Lacosamide	Lacosamide	26	suppressed
Primidone	Primidone	26	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	23	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	23	suppressed
Tradjenta	Linagliptin	23	suppressed
Ceftriaxone	Ceftriaxone Sodium	22	12
Lidocaine Hcl	Lidocaine Hcl	22	13
Nitrofurantoin	Nitrofurantoin Macrocrystal	22	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	21	suppressed
Nystop	Nystatin	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Amoxicillin	Amoxicillin	19	12
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	18	13
Dapsone	Dapsone	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Glipizide	Glipizide	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Prednisone	Prednisone	18	suppressed
Zenpep	Lipase/Protease/Amylase	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Ertapenem	Ertapenem Sodium	11	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	11	suppressed
Invega Sustenna	Paliperidone Palmitate	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Linezolid	Linezolid	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed
Roflumilast	Roflumilast	11	suppressed
Sodium Chloride	0.9 % Sodium Chloride	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error